Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies

Nonalcoholic fatty liver disease (NAFLD), a leading chronic disease worldwide, affects approximately a quarter of the global population. Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD and is more likely to progress to liver fibrosis than simple steatosis. NASH is also identified as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guang-Yan, Zhang, Xiao-Yan, Wang, Chun-Jiong, Guan, You-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850950/
https://www.ncbi.nlm.nih.gov/pubmed/36683713
http://dx.doi.org/10.3748/wjg.v29.i1.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850950/
https://www.ncbi.nlm.nih.gov/pubmed/36683713
http://dx.doi.org/10.3748/wjg.v29.i1.75

Ejemplares similares